Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture

Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.

Study Showing Xlear Nasal Spray Reduces COVID-19 Infections by 62%

Intranasal Xylitol for the Treatment of COVID-19 in the Outpatient Setting: A Pilot Study

Xlear | Sinus Care, Dental Defense,